Lake Oswego, Oregon – July 11, 2011 Scribes STAT, Inc. announced today that Mark Ahn, PhD has been appointed the Vice Chairman of the Scribes STAT Board of Directors.
Mark J. Ahn, Ph.D. is President & Chief Executive Officer, and Director of RXi Pharmaceuticals (Nasdaq: RXII). Prior to Rxi, Dr. Ahn was Principal at Pukana Partners, Ltd. that provides strategic consulting to life science companies; and Associate Professor, Global Management at Atkinson Graduate School of Management, Willamette University. He previously served as Chair, Science & Technology Management, Victoria University at Wellington, New Zealand. Dr. Ahn was also founder, President, and Chief Executive Officer of Hana Biosciences. Prior to Hana, he served as Vice President, Hematology and corporate officer at Genentech, Inc., as well as held positions of increasing responsibility at Amgen and Bristol-Myers Squibb Company; and served in the US Army. Dr. Ahn also serves on public and venture capital-backed Board of Directors for RXi Pharmaceuticals, Access Pharmaceuticals, and Mesynthes.
“Dr. Ahn’s position on the board will help ensure Scribes STAT’s growth with his vision and strategy for the company. His experience serving on other Boards of Directors will be invaluable,” stated Kathleen Myers, MD, Chairman & CEO of Scribes STAT.
About Scribes STAT
Scribes STAT is the premier provider of certified medical scribes who deliver accurate, real-time electronic medical records for emergency physicians and targeted specialty physicians resulting in improved physician efficiency, increased patient satisfaction, and timely and complete insurance billing. Scribes STAT is currently operating in Oregon and Washington in the Legacy Health System as well as medical clinics in the region. For more information, please visit: http://www.ScribesSTAT.com.